APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tofacitinib

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tofacitinib Industry Growth and Trends Forecast to 2032

23 December 202598 pages

Choose your research edition.

Industry ResearchTofacitinib Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Tofacitinib Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Tofacitinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tofacitinib Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Tofacitinib Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Tofacitinib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tofacitinib is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tofacitinib is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tofacitinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tofacitinib include Pfizer, Globe Pharmaceuticals, Drug International, Delta Pharma Limited and Beacon Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tofacitinib market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tofacitinib market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tofacitinib market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tofacitinib.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tofacitinib market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tofacitinib Market by Company

Pfizer

Globe Pharmaceuticals

Drug International

Delta Pharma Limited

Beacon Pharmaceuticals

Tofacitinib Segment by Type

5mg*60 Tablets

5mg*30 Tablets

5mg*14 Tablets

5mg*10 Tablets

10mg*14 Tablets

10mg*10 Tablets

Tofacitinib Segment by Application

Psoriasis

Rheumatoid Arthritis

Ulcerative Colitis

Others

Tofacitinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tofacitinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tofacitinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tofacitinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tofacitinib manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tofacitinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 5mg*60 Tablets Table 2. Major Company of 5mg*30 Tablets Table 3. Major Company of 5mg*14 Tablets Table 4. Major Company of 5mg*10 Tablets Table 5. Major Company of 10mg*14 Tablets Table 6. Major Company of 10mg*10 Tablets Table 7. Global Tofacitinib Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 9. Global Tofacitinib Sales Market Share in Volume by Type (2021-2026) Table 10. Global Tofacitinib Sales by Type (2021-2026) & (US$ Million) Table 11. Global Tofacitinib Sales Market Share in Value by Type (2021-2026) Table 12. Global Tofacitinib Price by Type (2021-2026) & (US$/pcs) Table 13. Global Tofacitinib Sales by Type (2027-2032) & (k pcs) Table 14. Global Tofacitinib Sales Market Share in Volume by Type (2027-2032) Table 15. Global Tofacitinib Sales by Type (2027-2032) & (US$ Million) Table 16. Global Tofacitinib Sales Market Share in Value by Type (2027-2032) Table 17. Global Tofacitinib Price by Type (2027-2032) & (US$/pcs) Table 18. North America Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 19. North America Tofacitinib Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 21. Europe Tofacitinib Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 23. Asia-Pacific Tofacitinib Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 25. Latin America Tofacitinib Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 27. Middle East and Africa Tofacitinib Sales by Type (2021-2026) & (US$ Million) Table 28. Tofacitinib Industry Trends Table 29. Tofacitinib Industry Drivers Table 30. Tofacitinib Industry Opportunities and Challenges Table 31. Tofacitinib Industry Restraints Table 32. Global Tofacitinib Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Tofacitinib Revenue Market Share by Company (2021-2026) Table 34. Global Tofacitinib Sales by Company (2021-2026) & (k pcs) Table 35. Global Tofacitinib Sales Share by Company (2021-2026) Table 36. Global Tofacitinib Market Price by Company (2021-2026) & (US$/pcs) Table 37. Global Tofacitinib Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Tofacitinib Major Company Production Sites and Headquarters Table 39. Global Tofacitinib Company, Product Type & Application Table 40. Global Tofacitinib Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Tofacitinib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Tofacitinib Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Tofacitinib Sales by Region (2021-2026) & (k pcs) Table 45. Global Tofacitinib Sales Market Share in Volume by Region (2021-2026) Table 46. Global Tofacitinib Sales by Region (2021-2026) & (US$ Million) Table 47. Global Tofacitinib Sales Market Share in Value by Region (2021-2026) Table 48. Global Tofacitinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 49. Global Tofacitinib Sales by Region (2027-2032) & (k pcs) Table 50. Global Tofacitinib Sales Market Share in Volume by Region (2027-2032) Table 51. Global Tofacitinib Sales by Region (2027-2032) & (US$ Million) Table 52. Global Tofacitinib Sales Market Share in Value by Region (2027-2032) Table 53. Global Tofacitinib Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 54. Global Tofacitinib Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 56. Global Tofacitinib Sales Market Share in Volume by Application (2021-2026) Table 57. Global Tofacitinib Sales by Application (2021-2026) & (US$ Million) Table 58. Global Tofacitinib Sales Market Share in Value by Application (2021-2026) Table 59. Global Tofacitinib Price by Application (2021-2026) & (US$/pcs) Table 60. Global Tofacitinib Sales by Application (2027-2032) & (k pcs) Table 61. Global Tofacitinib Sales Market Share in Volume by Application (2027-2032) Table 62. Global Tofacitinib Sales by Application (2027-2032) & (US$ Million) Table 63. Global Tofacitinib Sales Market Share in Value by Application (2027-2032) Table 64. Global Tofacitinib Price by Application (2027-2032) & (US$/pcs) Table 65. North America Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 66. North America Tofacitinib Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 68. Europe Tofacitinib Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 70. Asia-Pacific Tofacitinib Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 72. Latin America Tofacitinib Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 74. Middle East and Africa Tofacitinib Sales by Application (2021-2026) & (US$ Million) Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 78. Pfizer Tofacitinib Product Portfolio Table 79. Pfizer Recent Development Table 80. Globe Pharmaceuticals Company Information Table 81. Globe Pharmaceuticals Business Overview Table 82. Globe Pharmaceuticals Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 83. Globe Pharmaceuticals Tofacitinib Product Portfolio Table 84. Globe Pharmaceuticals Recent Development Table 85. Drug International Company Information Table 86. Drug International Business Overview Table 87. Drug International Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 88. Drug International Tofacitinib Product Portfolio Table 89. Drug International Recent Development Table 90. Delta Pharma Limited Company Information Table 91. Delta Pharma Limited Business Overview Table 92. Delta Pharma Limited Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 93. Delta Pharma Limited Tofacitinib Product Portfolio Table 94. Delta Pharma Limited Recent Development Table 95. Beacon Pharmaceuticals Company Information Table 96. Beacon Pharmaceuticals Business Overview Table 97. Beacon Pharmaceuticals Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 98. Beacon Pharmaceuticals Tofacitinib Product Portfolio Table 99. Beacon Pharmaceuticals Recent Development Table 100. North America Tofacitinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 101. North America Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 102. North America Tofacitinib Sales Market Share by Country (2021-2026) Table 103. North America Tofacitinib Sales Forecast by Country (2027-2032) & (k pcs) Table 104. North America Tofacitinib Sales Market Share Forecast by Country (2027-2032) Table 105. North America Tofacitinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 106. North America Tofacitinib Market Size by Country (2021-2026) & (US$ Million) Table 107. North America Tofacitinib Market Share by Country (2021-2026) Table 108. North America Tofacitinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 109. North America Tofacitinib Market Share Forecast by Country (2027-2032) Table 110. Europe Tofacitinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 111. Europe Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 112. Europe Tofacitinib Sales Market Share by Country (2021-2026) Table 113. Europe Tofacitinib Sales Forecast by Country (2027-2032) & (k pcs) Table 114. Europe Tofacitinib Sales Market Share Forecast by Country (2027-2032) Table 115. Europe Tofacitinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 116. Europe Tofacitinib Market Size by Country (2021-2026) & (US$ Million) Table 117. Europe Tofacitinib Market Share by Country (2021-2026) Table 118. Europe Tofacitinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 119. Europe Tofacitinib Market Share Forecast by Country (2027-2032) Table 120. Asia-Pacific Tofacitinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 121. Asia-Pacific Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 122. Asia-Pacific Tofacitinib Sales Market Share by Country (2021-2026) Table 123. Asia-Pacific Tofacitinib Sales Forecast by Country (2027-2032) & (k pcs) Table 124. Asia-Pacific Tofacitinib Sales Market Share Forecast by Country (2027-2032) Table 125. Asia-Pacific Tofacitinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 126. Asia-Pacific Tofacitinib Market Size by Country (2021-2026) & (US$ Million) Table 127. Asia-Pacific Tofacitinib Market Share by Country (2021-2026) Table 128. Asia-Pacific Tofacitinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 129. Asia-Pacific Tofacitinib Market Share Forecast by Country (2027-2032) Table 130. Latin America Tofacitinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 131. Latin America Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 132. Latin America Tofacitinib Sales Market Share by Country (2021-2026) Table 133. Latin America Tofacitinib Sales Forecast by Country (2027-2032) & (k pcs) Table 134. Latin America Tofacitinib Sales Market Share Forecast by Country (2027-2032) Table 135. Latin America Tofacitinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. Latin America Tofacitinib Market Size by Country (2021-2026) & (US$ Million) Table 137. Latin America Tofacitinib Market Share by Country (2021-2026) Table 138. Latin America Tofacitinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. Latin America Tofacitinib Market Share Forecast by Country (2027-2032) Table 140. Middle East and Africa Tofacitinib Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 141. Middle East and Africa Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 142. Middle East and Africa Tofacitinib Sales Market Share by Country (2021-2026) Table 143. Middle East and Africa Tofacitinib Sales Forecast by Country (2027-2032) & (k pcs) Table 144. Middle East and Africa Tofacitinib Sales Market Share Forecast by Country (2027-2032) Table 145. Middle East and Africa Tofacitinib Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Middle East and Africa Tofacitinib Market Size by Country (2021-2026) & (US$ Million) Table 147. Middle East and Africa Tofacitinib Market Share by Country (2021-2026) Table 148. Middle East and Africa Tofacitinib Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Middle East and Africa Tofacitinib Market Share Forecast by Country (2027-2032) Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Tofacitinib Distributors List Table 153. Tofacitinib Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Tofacitinib Image Figure 2. Global Tofacitinib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tofacitinib Market Size (2021-2032) & (US$ Million) Figure 4. Global Tofacitinib Sales (2021-2032) & (k pcs) Figure 5. 5mg*60 Tablets Image Figure 6. Global 5mg*60 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 7. 5mg*30 Tablets Image Figure 8. Global 5mg*30 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 9. 5mg*14 Tablets Image Figure 10. Global 5mg*14 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 11. 5mg*10 Tablets Image Figure 12. Global 5mg*10 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 13. 10mg*14 Tablets Image Figure 14. Global 10mg*14 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 15. 10mg*10 Tablets Image Figure 16. Global 10mg*10 Tablets Sales YoY Growth (2021-2032) & (k pcs) Figure 17. Global Tofacitinib Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Tofacitinib Market Share by Type 2025 VS 2032 Figure 19. North America Tofacitinib Sales Market Share in Volume by Type in 2025 Figure 20. North America Tofacitinib Sales Market Share in Value by Type in 2025 Figure 21. Europe Tofacitinib Sales Market Share in Volume by Type in 2025 Figure 22. Europe Tofacitinib Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Tofacitinib Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Tofacitinib Sales Market Share in Value by Type in 2025 Figure 25. Latin America Tofacitinib Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Tofacitinib Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Tofacitinib Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Tofacitinib Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Tofacitinib Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Psoriasis Image Figure 32. Global Psoriasis Sales YoY Growth (2021-2032) & (k pcs) Figure 33. Rheumatoid Arthritis Image Figure 34. Global Rheumatoid Arthritis Sales YoY Growth (2021-2032) & (k pcs) Figure 35. Ulcerative Colitis Image Figure 36. Global Ulcerative Colitis Sales YoY Growth (2021-2032) & (k pcs) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 39. Global Tofacitinib Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Tofacitinib Market Share by Application 2025 VS 2032 Figure 41. North America Tofacitinib Sales Market Share in Volume by Application in 2025 Figure 42. North America Tofacitinib Sales Market Share in Value by Application in 2025 Figure 43. Europe Tofacitinib Sales Market Share in Volume by Application in 2025 Figure 44. Europe Tofacitinib Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Tofacitinib Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Tofacitinib Sales Market Share in Value by Application in 2025 Figure 47. Latin America Tofacitinib Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Tofacitinib Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Tofacitinib Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Tofacitinib Sales Market Share in Value by Application in 2025 Figure 51. North America Tofacitinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 52. North America Tofacitinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Tofacitinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Tofacitinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Tofacitinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 56. Europe Tofacitinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Tofacitinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Tofacitinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Tofacitinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 60. Asia-Pacific Tofacitinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Tofacitinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Tofacitinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Tofacitinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 64. Latin America Tofacitinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Tofacitinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Tofacitinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Tofacitinib Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 68. Middle East and Africa Tofacitinib Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Tofacitinib Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Tofacitinib Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Tofacitinib Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Tofacitinib Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg*60 Tablets
  • 5mg*30 Tablets
  • 5mg*14 Tablets
  • 5mg*10 Tablets
  • 10mg*14 Tablets
  • 10mg*10 Tablets
Applications
  • Psoriasis
  • Rheumatoid Arthritis
  • Ulcerative Colitis
  • Others
Companies covered
  • Pfizer
  • Globe Pharmaceuticals
  • Drug International
  • Delta Pharma Limited
  • Beacon Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tofacitinib Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tofacitinib Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tofacitinib Market by Type
  6. 1.3.1 5mg*60 Tablets
  7. 1.3.2 5mg*30 Tablets
  8. 1.3.3 5mg*14 Tablets
  9. 1.3.4 5mg*10 Tablets
  10. 1.3.5 10mg*14 Tablets
  11. 1.3.6 10mg*10 Tablets
  12. 1.4 Global Tofacitinib Market Size by Type
  13. 1.4.1 Global Tofacitinib Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Tofacitinib Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Tofacitinib Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Tofacitinib Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Tofacitinib Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Tofacitinib Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Tofacitinib Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Tofacitinib Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tofacitinib Industry Trends
  2. 2.2 Tofacitinib Industry Drivers
  3. 2.3 Tofacitinib Industry Opportunities and Challenges
  4. 2.4 Tofacitinib Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tofacitinib Revenue (2021-2026)
  2. 3.2 Global Top Players by Tofacitinib Sales (2021-2026)
  3. 3.3 Global Top Players by Tofacitinib Price (2021-2026)
  4. 3.4 Global Tofacitinib Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tofacitinib Major Company Production Sites & Headquarters
  6. 3.6 Global Tofacitinib Company, Product Type & Application
  7. 3.7 Global Tofacitinib Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tofacitinib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tofacitinib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tofacitinib Tier 1, Tier 2, and Tier 3
4 Tofacitinib Regional Status and Outlook
  1. 4.1 Global Tofacitinib Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tofacitinib Historic Market Size by Region
  3. 4.2.1 Global Tofacitinib Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tofacitinib Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tofacitinib Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tofacitinib Forecasted Market Size by Region
  7. 4.3.1 Global Tofacitinib Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tofacitinib Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tofacitinib Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tofacitinib by Application
  1. 5.1 Tofacitinib Market by Application
  2. 5.1.1 Psoriasis
  3. 5.1.2 Rheumatoid Arthritis
  4. 5.1.3 Ulcerative Colitis
  5. 5.1.4 Others
  6. 5.2 Global Tofacitinib Market Size by Application
  7. 5.2.1 Global Tofacitinib Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Tofacitinib Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Tofacitinib Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Tofacitinib Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Tofacitinib Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Tofacitinib Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Tofacitinib Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Tofacitinib Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Tofacitinib Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Tofacitinib Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 Globe Pharmaceuticals
  8. 6.2.1 Globe Pharmaceuticals Company Information
  9. 6.2.2 Globe Pharmaceuticals Business Overview
  10. 6.2.3 Globe Pharmaceuticals Tofacitinib Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Globe Pharmaceuticals Tofacitinib Product Portfolio
  12. 6.2.5 Globe Pharmaceuticals Recent Developments
  13. 6.3 Drug International
  14. 6.3.1 Drug International Company Information
  15. 6.3.2 Drug International Business Overview
  16. 6.3.3 Drug International Tofacitinib Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Drug International Tofacitinib Product Portfolio
  18. 6.3.5 Drug International Recent Developments
  19. 6.4 Delta Pharma Limited
  20. 6.4.1 Delta Pharma Limited Company Information
  21. 6.4.2 Delta Pharma Limited Business Overview
  22. 6.4.3 Delta Pharma Limited Tofacitinib Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Delta Pharma Limited Tofacitinib Product Portfolio
  24. 6.4.5 Delta Pharma Limited Recent Developments
  25. 6.5 Beacon Pharmaceuticals
  26. 6.5.1 Beacon Pharmaceuticals Company Information
  27. 6.5.2 Beacon Pharmaceuticals Business Overview
  28. 6.5.3 Beacon Pharmaceuticals Tofacitinib Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Beacon Pharmaceuticals Tofacitinib Product Portfolio
  30. 6.5.5 Beacon Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Tofacitinib Sales by Country
  2. 7.1.1 North America Tofacitinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tofacitinib Sales by Country (2021-2026)
  4. 7.1.3 North America Tofacitinib Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tofacitinib Market Size by Country
  6. 7.2.1 North America Tofacitinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tofacitinib Market Size by Country (2021-2026)
  8. 7.2.3 North America Tofacitinib Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tofacitinib Sales by Country
  2. 8.1.1 Europe Tofacitinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tofacitinib Sales by Country (2021-2026)
  4. 8.1.3 Europe Tofacitinib Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tofacitinib Market Size by Country
  6. 8.2.1 Europe Tofacitinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tofacitinib Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tofacitinib Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tofacitinib Sales by Country
  2. 9.1.1 Asia-Pacific Tofacitinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tofacitinib Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tofacitinib Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tofacitinib Market Size by Country
  6. 9.2.1 Asia-Pacific Tofacitinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tofacitinib Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tofacitinib Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tofacitinib Sales by Country
  2. 10.1.1 South America Tofacitinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tofacitinib Sales by Country (2021-2026)
  4. 10.1.3 South America Tofacitinib Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tofacitinib Market Size by Country
  6. 10.2.1 South America Tofacitinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tofacitinib Market Size by Country (2021-2026)
  8. 10.2.3 South America Tofacitinib Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tofacitinib Sales by Country
  2. 11.1.1 Middle East and Africa Tofacitinib Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tofacitinib Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tofacitinib Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tofacitinib Market Size by Country
  6. 11.2.1 Middle East and Africa Tofacitinib Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tofacitinib Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tofacitinib Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tofacitinib Value Chain Analysis
  2. 12.1.1 Tofacitinib Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tofacitinib Production Mode & Process
  7. 12.2 Tofacitinib Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tofacitinib Distributors
  10. 12.2.3 Tofacitinib Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst